On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridaySep 17, 2021 4:20 pm

420 with CNW — Federal Financial Regulator Criticizes Congress for Failing to Reform Marijuana Laws

Rodney Hood, the former chairman of the National Credit Union Administration (“NCUA”) has criticized Congress for failing to reform cannabis laws. The NCUA is an independent federal agency that offers deposit insurance to credit unions. Hood served as a regulator from 2005–09, before becoming chairman in 2019 and transitioning to a board position. The regulator announced last week at the PBC conference that he would be taking steps to push legislators to enact changes in policy that help stakeholders and financial institutions. He stated that he was concerned that the regulatory and legal infrastructure surrounding the marijuana industry wasn’t evolving…

Continue Reading

FridaySep 17, 2021 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Signs Definitive Agreement to Acquire 100% of BayMedica Inc., Positioning it to Stand Distinct in Rare Cannabinoids Manufacturing, Become a Revenue-Generating Company, Expand Drug Development Capabilities

InMed Pharmaceuticals recently announced it has entered a definitive agreement to acquire 100% of BayMedica Inc. BayMedica is a private company that specializes in the manufacture and commercialization of rare cannabinoids Upon closing, the transaction will make InMed a global leader in the manufacturing of rare cannabinoids in addition to transforming it into a revenue-generating company Acquisition provides InMed with the complete flexibility across multiple manufacturing approaches On September 13, InMed Pharmaceuticals (NASDAQ: INM), a company developing cannabinoid-based pharmaceutical drug candidates and manufacturing technologies for pharmaceutical-grade rare cannabinoids, announced it has signed a definitive agreement to acquire 100% of BayMedica…

Continue Reading

FridaySep 17, 2021 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Draws Closer to NDA Filing for DehydraTECH CBD

Lexaria just released the most important results yet from its ongoing HYPER-H21-2 human clinical trials on the effects of the company’s patented DehydraTECH(TM)-processed CBD on blood pressure Chris Bunka, Lexaria’s CEO, termed the results as “statistically significant” Participants in the study reported up to an average 23% decrease in blood pressure and a 7% drop in systolic pressure These results bring Lexaria closer to NDA filing with the FDA, making it a pioneer in CBD hypertension treatment  Lexaria Bioscience (NASDAQ: LEXX) just released the most recent results from its ongoing HYPER-H21-2 human clinical trials on the effects of the company’s…

Continue Reading

FridaySep 17, 2021 4:20 am

420 with CNW — National Hemp Association Requests $1B from Congress to Boost Industry Innovation

America’s hemp industry may be young, but it is brimming with potential just a couple of years after the 2018 Farm Bill legalized the cultivation and sale of hemp and its derivatives. But while the American hemp industry was valued at $5.66 billion in 2020 and is projected to see major growth over the next decade, it hasn’t received much government support. And given that hemp is a versatile product with a wide variety of applications ranging from cloth, cosmetics, and rope to printer's ink, wood preservative and a construction material called hempcrete, government investment could turn the nascent hemp…

Continue Reading

ThursdaySep 16, 2021 4:20 pm

420 with CNW — Report Finds Young People’s Views on Cannabis Use Is Changing

As more states across the country legalize cannabis for recreational use, attitudes toward the use of cannabis is changing. A report that was recently released by the National Institute on Drug Abuse has found that the number of young individuals who view the use of cannabis as risky behavior has decreased. According to the report, young individuals believe that in comparison to the occasional use of cannabis, vaping cannabis is riskier. They also think that experimenting with other drugs, including LSD, sedatives, heroin or cocaine, is riskier than experimenting with cannabis. The National Institute on Drug Abuse has been tracking…

Continue Reading

ThursdaySep 16, 2021 1:16 pm

Roth’s Investing in Women Cannabis Pioneers Investor Conference to Feature Female-Led Companies within the North American Cannabis Sector

Roth Capital Partners will host the “Women Cannabis Pioneers - The Brand Builders” event on September 28, 2021 The conference is set to feature approximately 25 privately held and female-led companies operating within the North American cannabis market Institutional investors will have an opportunity to discover new investment opportunities through their interaction with a host of emerging and lesser-known privately held companies Hosted by Roth Capital Partners (“Roth”), a widely respected independent securities research and trading firm specializing in emerging growth companies, the Investing in Women Cannabis Pioneers – The Brand Builders event has been uniquely designed to highlight the…

Continue Reading

ThursdaySep 16, 2021 4:20 am

420 with CNW — CBD Trademarking Judgment Highlights Problems of FDA Regulatory Delays

The cannabidiol (“CBD”) industry has grown a great deal in the few years that it has been legal, achieving a market size value of $2.8 billion in 2020. Demand for CBD-infused products has been on the rise, thanks to reports of its potent medicinal properties, and a multitude of sellers have entered the CBD space looking to capture a swathe of the market for themselves before it becomes too saturated. However, it hasn’t been a walk in the park for these companies, thanks to a variety of barriers, the main one being the fact that the CBD industry does not…

Continue Reading

WednesdaySep 15, 2021 4:20 pm

420 with CNW — Labor Day Cannabis Sales Rank Among Highest

Cannabis sales were expected to increase over the last week’s Labor Day weekend and on Labor Day itself. A report that was recently released by Akerna, a marijuana technology company, states that nearly $240 million in national legal marijuana sales were expected for this holiday weekend. The report noted that the increase was projected to begin on Friday, with roughly $90 million in cannabis sales, which equates to a 61% increase from an average Friday. Saturday was projected to see almost $70 million in legal sales while Sunday was expected to bring in $39 million. On Labor Day itself (Monday),…

Continue Reading

WednesdaySep 15, 2021 2:37 pm

Flora Growth Corp. (NASDAQ: FLGC) Receives its 2021 Commercial Export Quota Allocation from Colombian Government; Partners to Optimize Its Supply Chain By Implementing Global Cannabis Product Validation and Authentication Platform

Flora also recently announced it had received its 2021 commercial export quota allocation of 7,900 kilograms to cultivate, process, and distribute high-THC cannabis Flora Growth also announced it has entered into an agreement with Applied DNA Sciences, Inc. and TruTrace Technologies, Inc.  FLGC will deploy the two companies’ integrated technology as part of its global cannabis product validation and authentication platform The integrated technology will tag, test, and track Flora’s cannabis and cannabis derivative products during transit across an international supply chain, providing enhanced transparency, traceability, and trust As an internationally focused company, Flora Growth (NASDAQ: FLGC) has always strived…

Continue Reading

WednesdaySep 15, 2021 12:45 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Making Great Strides Toward Filing IND Application for Patented DehydraTECH(TM) Technology

Lexaria has begun the formal process of preparing an application for Investigational New Drug status for DehydraTECH(TM) and cannabidiol for hypertension The filing is being done with the assistance of an outside consultancy group, with Lexaria Bioscience designing non-clinical, clinical, and related product development required prior to the filing – all of which support Lexaria’s more ambitious goals There have been two successful human hypertension trials done with the combination DehydraTECH-CBD therapy in 2021, following an original human clinical study in 2018, and many animal studies Lexaria is making a strong case to support the efficacy of the technology for…

Continue Reading

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo USA CBD Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722